MI Sign Up for eTOC Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Molecular Interventions 5:73-79, (2005)
© American Society for Pharmacology and Experimental Therapeutics
10.1124/mi.5.2.4
This Article
Right arrow Summary Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Galione, A.
Right arrow Articles by Petersen, O. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galione, A.
Right arrow Articles by Petersen, O. H.

Viewpoint

The NAADP Receptor: New Receptors or New Regulation?

Antony Galione1 and Ole H. Petersen2

1 Department of Pharmacology, University of Oxford, Mansfield Road, Oxford, OX1 3QT, UK;
2 The Physiological Laboratory, University of Liverpool, Crown Street, Liverpool, L69 3BX, UK

SUMMARY

Nicotinic acid adenine dinucleotide phosphate (NAADP) is the most potent calcium mobilizing messenger yet discovered. Its action has now been reported in a large number of cell types from a diverse array of organisms, and in some cases linked to the transduction of specific cellular stimuli. However, what is controversial is the nature of its target calcium release channel, as well as the subcellular localization of its receptor. Some have proposed that NAADP activates a novel calcium release channel distinct from the two major classes of channels known, the inositol trisphosphate receptors and ryanodine receptors. However, others have suggested that it acts in a novel way to regulate a known calcium release channel, the ryanodine receptor.

Nicotinic acid adenine dinucleotide phosphate (NAADP) is structurally related to the well-known coenzyme nicotinamide adenine dinucleotide phosphate (NADP), the only difference being the replacement of the nicotinamide moiety by nicotinic acid. In contrast to NADP, NAADP is a potent activator of Ca2+ release from intracellular stores, and in some cases also Ca2+ influx. Such effects have been reported in a wide range of cells and preparations across the phylogenic spectrum. We discuss below on the basis of current work whether NAADP acts on a novel Ca2+-release mechanism or regulates known Ca2+-release channels by novel mechanisms.

The chemical synthesis of NAADP was first described by Bernofsky, who prepared it through an enzymic base-exchange reaction by incubating NADP and nicotinic acid with calf spleen NAD glycohydrolase (1). It was not until 1987, however, that the potent Ca2+-releasing activities of NAADP were reported, as an unidentified contaminant of commercially available NADP (2), which released Ca2+ from vesicular stores in sea urchin egg homogenates. The amount of this contaminant was increased by treating NADP with alkali. Subsequent analysis by HPLC and high resolution mass spectroscopy identified the Ca2+-mobilizing compound as NAADP (3).

The initial studies in sea urchin egg homogenates of alkali-activated NADP-evoked Ca2+ release (2) and, once identified, NAADP-induced Ca2+ release (3, 4), indicated that the release mechanism did not involve the inositol-1,4,5-trisphosphate (InsP3) receptor (IP3R). Indeed, NAADP-, cyclic adenosine diphosphate ribose (cADPR)-, and InsP3-sensitive Ca2+-release mechanisms exhibit specific desensitization, in that, regardless of the order of addition, each agent added at its maximal concentration renders homogenates or microsomes insensitive to further Ca2+ release by the same agent, but fully sensitive to the others (3). These results suggested that there were at least three separate Ca2+ release mechanisms present in sea urchin homogenates.

Pharmacological experiments using selective inhibitors of IP3Rs such as heparin, and those of ryanodine receptors (RyRs), for example ryanodine, ruthenium red and procaine (as well as inhibitory structural analogs of cADPR), indicated that whereas cADPR most likely activates RyRs, NAADP activates a Ca2+-release mechanism that was most likely distinct from IP3Rs and RyRs. Similar results were observed in intact sea urchin eggs injected with IP3Rs or RyR inhibitors in response to photolysis of caged NAADP (5). Although the pharmacology of NAADP-induced Ca2+ release has not been extensively studied, NAADP-sensitive Ca2+-release channels are blocked, noncompetitively, by concentrations of dihydropyridines, gallopamil (also termed methoxyverapamil or D600), or diltiazem that, although being somewhat higher than those required to block voltage-gated Ca2+ channels (Table 1Go), nevertheless do not affect Ca2+ release via either IP3Rs or RyRs (6).


View this table:
[in this window]
[in a new window]
 
Table 1. Pharmacology of the Inhibition of NAADP-Induced Ca2+ Release
 
A hallmark of both IP3R- and RyR-mediated Ca2+ release is that both Ca2+ release channels are modulated in such a way by Ca2+ itself that they are said to mediate Ca2+-induced Ca2+ release (CICR), a process thought to underlie many of the complex spatio-temporal complexities of Ca2+ signaling patterns widely observed in all cell types (7). In contrast, in sea urchin egg homogenates, the NAADP-sensitive Ca2+-release mechanism is insensitive to Ca2+, and resistant to block by millimolar concentrations of Mg2+, which block CICR (6, 8). Thus, in intact sea urchin eggs, NAADP induces localized Ca2+ release, which can lead to regenerative Ca2+ waves, but only if IP3Rs and RyRs are subsequently recruited (5).

Early studies of Percoll-gradient fractionation of alkali-activated NADP-induced Ca2+ release showed that this mechanism regulated release from a nonmitochondrial store devoid of cytochrome c activity, which was separate from those activated by InsP3 or cADPR (generated from NAD+) (2). IP3Rs and RyRs are well-characterized as mainly residing in (sarco-) endoplasmic reticulum (ER) Ca2+ stores, the site of Ca2+ sequestration by thapsigargin-sensitive sarco-endoplasmic reticulum Ca2+ ATPases (SERCA pumps). Whereas thapsigargin, as expected, depletes InsP3-sensitive and cADPR-sensitive Ca2+ stores in both sea urchin egg homogenates (6) and intact eggs (9), NAADP-sensitive stores remain largely unaffected by this treatment. Further evidence for NAADP-sensitive stores being discrete from the ER comes from elegant experiments using stratified sea urchin eggs. Centrifugation of eggs results in the formation of elongated structures in which organelles are stratified in distinct regions. Fluorescence-tagged thapsigargin labels structures at the nuclear pole, which is also the site of both InsP3- and cADPR-induced Ca2+ release. In contrast, NAADP-sensitivity, functionally visualized by Ca2+ imaging, is located at the opposite pole enriched in mitochondria (10) and acidic compartments (11). NAADP-sensitive stores are unlikely to be mitochondria because they express a paucity of mitochondrial markers, thus, acidic organelles emerged as plausible candidates. More-detailed Percoll fractionations of sea urchin egg homogenate allowed the purification of NAADP-sensitive Ca2+ stores with minimal InsP3 or cADPR sensitivity. These stores colocalized with egg reserve granules—functionally equivalent to secretory lysosomes—which are also involved in plasma membrane repair following mechanical wounding (12, 13), providing one explanation for the presence of NAADP-sensitive Ca2+ influx pathways in the plasma membrane (1416). These stores are enriched in [32P]-NAADP binding sites and lysosomal markers, and sequester Ca2+ which may be discharged by NAADP (11). The vacuolar proton pump inhibitor bafilomycin and various protonophores abrogate this Ca2+ sequestration, and the lysomotropic agent glycyl-L-phenylalanine-ß-naphthylamide (GPN) abolishes NAADP-induced Ca2+ release. In intact eggs, as well as in egg homogenates, GPN and bafilomycin selectively abolish NAADP- but not InsP3- or cADPRevoked Ca2+ release (Table 1Go). Taken together, these data are consistent with a mechanism whereby NAADP-sensitive release is located in thapsigargin-insensitive acidic Ca2+ stores (11).

The nature of the NAADP receptor in sea urchin egg homogenates has been probed by characterizing [32P]-NAADP–binding proteins. Binding is essentially irreversible in this preparation, and, together with the high binding capacity, make it a system of choice for the purification and molecular characterization of these proteins. [32P]-NAADP binds to a single population of high affinity binding sites (Kd ~ 0.3 nM, Bmax ~ 125 fmol/mg protein) on sea urchin egg homogenate membranes (17, 18). Detergent-solubilized [32P]- NAADP–binding proteins display similar binding characteristics to those found in native membranes, indicating that they are intrinsic membrane proteins, and gel-filtration molecular size analysis indicates that they are substantially smaller than either native IP3Rs or RyRs (19).

NAADP-induced Ca2+ release is also widespread in mammalian systems. The exocrine pancreatic acinar cell was the first intact mammalian cell type in which NAADP-induced Ca2+ release was reported (20), but studies on mammalian exocrine cells, in general, have also been crucial for developing our current view of intracellular Ca2+ signaling events. Experiments on the perfused cat submandibular gland provided the earliest evidence for agonist-elicited release of Ca2+ from non-mitochondrial intracellular stores, also demonstrating cellular extrusion of Ca2+ by active transport and, after a delay, activation of Ca2+ entry (21). Studies on permeabilized pancreatic acinar cells demonstrated for the first time that InsP3 releases Ca2+ from a non-mitochondrial store (22).

Combining patch-clamp whole-cell recording of Ca2+-activated Cl current with fluorescence measurement of the cytosolic Ca2+ concentration (23, 24) has made it possible to probe directly the action of various intracellular messengers in pancreatic acinar cells (2326). In this way, InsP3 (25, 27), cADPR (26), and NAADP (20, 24, 28) were shown to elicit repetitive local cytosolic Ca2+ spikes in the apical granular pole. The local apical Ca2+ spiking depends on concerted activity of RyRs and IP3Rs (28, 29).

The two physiological activators of pancreatic acinar secretion, acetylcholine (ACh) and cholecystokinin (CCK), initiate Ca2+ spiking via different messenger pathways. Inactivation of NAADP-evoked Ca2+ release in mammalian cells occurs at high concentrations of NAADP (20). This is in contrast to the situation in sea urchin eggs, where concentrations that are below the threshold for inducing Ca2+ release fully desensitize the release mechanism (14). Inactivation of NAADP receptors by intracellular application of NAADP at a high concentration (µM) blocks Ca2+ spiking elicited by physiological CCK concentrations (1–10 pM) (20, 28), but has no effect on Ca2+ spiking responses elicited by ACh (28) or bombesin (30). Physiological Ca2+ signaling elicited by CCK, therefore, has a unique requirement for functional intracellular NAADP receptors.

How and from which intracellular store does NAADP elicit Ca2+ release in the acinar cells? This is difficult to answer on the basis of studies in intact acinar cells, because the apical granular pole, where the NAADP-induced Ca2+ spiking occurs, contains two major Ca2+ pools located in the endoplasmic reticulum (ER) and the zymogen granules (ZGs) (31). The ER is generally considered to be the main Ca2+ store from which cytosolic Ca2+ signals are generated (32), therefore, it would seem desirable to test the action of NAADP on a pure ER preparation. The nucleus may, in practice, constitute such a preparation. The outer nuclear membrane is continuous with the ER membrane and the lumen of the nuclear envelope is continuous with the ER lumen (33). Studies on isolated liver nuclei have demonstrated active, ATP-dependent and thapsigargin-sensitive Ca2+ uptake into the nuclear envelope, and InsP3 and cADPR liberate Ca2+ from this store (34). More recent studies on isolated nuclei from pancreatic acinar cells, which also contain several layers of surrounding ER, demonstrate that the thapsigarginsensitive Ca2+ store can release Ca2+ in response to stimulation, not only with InsP3 or cADPR, but also with NAADP (35). Data obtained from this preparation show that the Ca2+ liberation elicited by NAADP (and also by cADPR) can be blocked by ryanodine or ruthenium red, but not by caffeine. Alternately, the Ca2+ release evoked by InsP3 is blocked by caffeine (acting as an IP3R antagonist), but not by ryanodine or ruthenium red (35). Therefore, the simplest hypothesis to account for these data is that NAADP, like cADPR, causes Ca2+ release from the ER by opening RyRs. NAADP and cADPR act on separate receptor sites, because inactivation of NAADP receptors by a high NAADP concentration (µM) does not prevent cADPR-elicited Ca2+ release (35).

In pancreatic acinar cells, CCK and NAADP can also release Ca2+ from an acidic, bafilomycin-sensitive, but thapsigargin-insensitive, Ca2+ store located in the apical granular pole (36) that new, as yet unpublished results suggest, does not have characteristics of the ER. Ca2+ can be released from this acidic granular store by either InsP3, cADPR, or NAADP. As is the case for the ER, the actions of NAADP and cADPR on the acidic store can be abolished by RyR inhibitors, whereas the action of InsP3 can only be blocked by IP3R antagonists. It has been proposed that the acid pool from which NAADP releases Ca2+ could be in lysosome-related organelles, including ZGs (36). The ZGs have an extraordinarily high total Ca2+ concentration (>10 mM) (37) and isolated single ZGs can release Ca2+ in response to both InsP3 or cADPR (37). So far, the action of NAADP has not been tested on ZGs. Because cytosolic Ca2+ signals generated by stimulation with InsP3, cADPR, or NAADP are remarkably similar (24), it seems possible, even likely, that NAADP could also liberate Ca2+ from isolated ZGs.

Apical Ca2+ signals are of strategic importance for the control of pancreatic enzyme and fluid secretion (38, 39). It appears that the reason for the particular sensitivity of the apical region of pancreatic acinar cells to Ca2+-releasing stimuli is the close proximity, in this part of the cell, of two separate Ca2+ stores, both having a full complement of Ca2+-releasing channels. Given the fact that CICR only initiates in the apical pole and depends on the dual function of both RyRs and IP3Rs (29), it does not seem unreasonable to propose that the apical Ca2+ spikes arise from CICR interactions between these receptors on both types of Ca2+ stores.

Although sea urchin eggs and pancreatic acinar cells are the most intensely studied systems in which the actions and role of NAADP in Ca2+ signaling have been investigated, there is a growing list of other cell types in which NAADP participates as an important Ca2+-releasing messenger. Rat brain microsomes were the first mammalian preparation in which NAADP-induced Ca2+ release was demonstrated (40). In this preparation, the NAADP-regulated Ca2+ release mechanism, as in sea urchin eggs, was independent of extravesicular Ca2+ concentrations, was unaffected by IP3R and RyR inhibitors, but was inhibited by micromolar concentrations of dihyropyridines or diltiazem. These findings were mirrored in studies on cholinergic motoneurons from Aplysia, where NAADP-evoked Ca2+ release was not blocked by heparin or by ryanodine either alone or together (41). Similarly in frog neuromuscular preparations, NAADP-induced increases in transmitter release from prejunctional neurons were not affected by either ryanodine or thapsigargin (42, 43). In rat cortical neurons, NAADP-evoked increases in Ca2+ were thapsigargin- insensitive but again blocked by bafilomycin (44); however, NAADP-induced Ca2+ transients were reduced but not abolished by ryanodine or heparin treatments. These data are consistent with the suggestion that NAADP activates a distinct Ca2+ release mechanism on acidic compartments, that can, in turn, be amplified by recruiting IP3Rs and RyRs, presumably by CICR.

Pancreatic beta cells also express an NAADP-sensitive Ca2+-release mechanism. In human pancreatic beta cells, NAADP mobilizes Ca2+ from a pool that is insensitive to either ryanodine or the IP3R antagonist, xestospongin C, and might mediate the autocrine inhibitory effects of insulin on further release of this hormone (45). In this study, and in a report of the pancreatic beta MIN6 cell line (46), nanomolar concentrations of NAADP induced Ca2+ release, whereas micromolar concentrations inactivated the release mechanism. Because micromolar concentrations of NAADP blocked glucose-induced Ca2+ spiking and because glucose administration increased NAADP levels, a messenger role was proposed for NAADP in stimulus-secretion coupling in pancreatic beta cells (46, 47). These findings were extended in MIN6 cells to show that NAADP mobilizes Ca2+ through a thapsigargin- and ryanodine-insensitive mechanism in secretory granules (SGs) rather than in the ER (48). These results were complemented by a study in intact MIN6 cells, in which NAADP-evoked Ca2+ release was blocked by bafilomycin but not thapsigargin (36).

Smooth muscle is another system in which NAADP-evoked Ca2+ release has been observed. In intact pulmonary arterial myocytes, NAADP mobilizes Ca2+ from a bafilomycin-sensitive store. Whereas xestospongin C had little effect on NAADP-induced Ca2+ release, both ryanodine or thapsigargin reduced but did not abolish NAADP’s effects (49, 50). Thus, as in other systems, local NAADP-induced Ca2+ release from acidic stores might be amplified by CICR through the recruitment of RYRs on the ER located proximal to NAADP-activated receptors (50). In rat aortic microsomes, NAADP released Ca2+ by a mechanism insensitive to IP3R or RyR blockers but which was inhibited by dihydropyridines (51). In striated muscle, NAADP released Ca2+ from rat heart microsomes, which was unaffected by ryanodine and divalent cations, but blocked by dihydropyridines (52); however, it should be noted that direct interactions of NAADP with purified RyRs from both skeletal (53) and cardiac muscle (54) have been reported by some but not others (55).

Interactions between Ca2+-release mechanisms are important in T-cell activation. NAADP evokes Ca2+ release with a concentration- dependence similar to that evinced in both pancreatic acinar and beta cells: nanomolar concentrations activated, but micromolar concentrations inhibited Ca2+ release (56). Through the use of high, inactivating NAADP concentrations, T cell receptor–mediated activation was inhibited as was, perhaps more puzzlingly, Ca2+ release by InsP3 or cADPR. A follow-up study showed that knock-down studies of RyRs (by utilizing antisense mRNA technology) in Jurkat cells— and experiments that inhibited RyRs with ruthenium red—reduced but did not totally abolish NAADP-induced Ca2+ release (16). Based on these studies, it is difficult to distinguish between a direct effect of NAADP on RyRs or an indirect effect involving amplification of NAADP-induced Ca2+ release by RyRs. There is a single report that NAADP may also operate as a Ca2+-mobilizing messenger in plants. In both red beet and cauliflower, it appears that NAADP releases Ca2+ from the ER rather than vacuolar membranes (57) through a mechanism insensitive to either heparin or 8-NH2-cADPR or dihydropyridines, but blocked by ruthenium red, suggesting that it activates a novel Ca2+-release mechanism.

There are now numerous studies showing that NAADP is an extremely potent Ca2+-mobilizing messenger as well as a regulator of Ca2+ influx in a wide range of cell types from a variety of organisms including mammals and humans (Table 1Go). NAADP was initially implicated as a Ca2+-mobilizing messenger for different agonists in several cell types through the use of protocols that inactivated NAADP-mediated Ca2+ release; these findings have now been confirmed by direct NAADP measurements (14, 46, 50). The precise biosynthetic pathway for NAADP is unclear, although CD38 can catalyze synthesis by a base-exchange mechanism in vitro (58). Another major uncertainty is the nature and cellular location of NAADP-sensitive Ca2+-release channels. Although in many studies, NAADP-evoked Ca2+ release may be insensitive to IP3R and RyR blockers but inhibited by agents such as dihydropyridines, more often than not RyR inhibitors reduce NAADP-mediated Ca2+ release. However, because different Ca2+-release channels often interact to shape Ca2+ signaling patterns (29, 59), it is not trivial to distinguish between a direct action of NAADP at RyRs or an action at a distinct and novel Ca2+-release channel followed by amplification by RyR-mediated CICR (Figure 1Go). If a direct action is the case, then there is a certain degree of novelty and selectivity as to the mechanism of regulation. If the latter scenario proves correct, then it is likely that we have been confounded by variations in the tightness of coupling between the separate mechanisms in different cells. Another possibility is that NAADP-binding proteins, although likely to be intrinsic membrane proteins (19), are promiscuous and are not intrinsic Ca2+-release channels, but regulators of known Ca2+ channels such as RyRs, and dihydropyridine-sensitive Ca2+ channels, among others. This hypothesis may also explain the apparent heterogeneity of Ca2+ stores that NAADP apparently discharges, with NAADP modulating the Ca2+ channels found in these different subcellular locations. These scenarios will only be unequivocally resolved by the purification and characterization of NAADP-binding proteins.



View larger version (31K):
[in this window]
[in a new window]
 
Figure 1. Possible mechanisms for NAADP-induced calcium release. Direct model: NAADP binds directly to the RyR on Ca2+ stores (ER or acidic compartments) increasing the probability of the channel being open (53, 54). NAADP may also bind and directly regulate plasma membrane (pm) Ca2+ channels (PMCC). Trigger CICR model: This model assumes that there is a discrete NAADP receptor/Ca2+-release channel that is located in a discrete Ca2+-storage organelle (probably an acidic store) (store 1). Localized Ca2+ release from this pool then recruits IP3Rs and RyRs located in a second store [the ER (store 2)] by CICR and globalizes the Ca2+ signals (5, 20). Promiscuous coupling model: In this model, the NAADP-binding protein is not a Ca2+ channel per se, but rather is an integral membrane protein that can associate and regulate Ca2+-release channels such as RyRs (35), in the ER or acidic stores (including secretory granules), or calcium influx channels in the plasma membrane. Conformational coupling model: This model assumes that NAADP interacts directly with a distinct NAADP-regulated Ca2+-release channel in a discrete store. This channel can release Ca2+ in response to NAADP, but the channel may also directly interact with other Ca2+-release channels (IP3Rs or RyRs) or with plasma membrane Ca2+-influx channels. This model provides one explanation for how desensitizing concentrations of NAADP apparently render IP3Rs or RyRs insensitive to their respective agonists (56) or desensitize Ca2+ influx (14), even in the apparent absence of Ca2+ release. Permutations of any of the four models above are also possible. Another possibility is that distinct subtypes of NAADP receptors exist with different localizations, pharmacology, and functions.

 

Antony Galione, PhD, is a Professor of Pharmacology and a Wellcome Senior Fellow in Basic Biomedical Science at The University of Oxford, UK. E-mail antony.galione{at}pharm.ox.ac.uk; fax +44 1865 271 853.


Ole H. Petersen, FRS, is Medical Research Council Professor in Physiology, at The University of Liverpool, UK. E-mail o.h.petersen{at}liv.ac.uk; fax +44 151 794 5323.

References

  1. Bernofsky, C. (1980). Nicotinic acid adenine dinucleotide phosphate (NAADP+). In Methods Enzymol., vol. 66, pp. 105–112: Academic Press Inc.
  2. Clapper, D.L., Walseth, T.F., Dargie, P.J., and Lee, H.C. Pyridine nucleotide metabolites stimulate calcium release from sea urchin egg microsomes desensitized to inositol trisphosphate. J. Biol. Chem. 262, 9561–9568 (1987). A landmark paper first indicating the existence of multiple Ca2+-mobilizing messengers.[Abstract/Free Full Text]
  3. Lee, H.C. and Aarhus, R. A derivative of NADP mobilizes calcium stores insensitive to inositol trisphosphate and cyclic ADP-ribose. J. Biol. Chem. 270, 2152–2157 (1995). The first report of NAADP as a Ca2+-mobilizing molecule.[Abstract/Free Full Text]
  4. Chini, E.N., Beers, K.W., and Dousa, T.P. Nicotinate adenine dinucleotide phosphate (NAADP) triggers a specific calcium release system in sea urchin eggs. J. Biol. Chem. 270, 3216–3223 (1995).[Abstract/Free Full Text]
  5. Churchill, G.C. and Galione, A. Spatial control of Ca2+ signaling by nicotinic acid adenine dinucleotide phosphate diffusion and gradients. J. Biol. Chem. 275, 38687–38692 (2000).[Abstract/Free Full Text]
  6. Genazzani, A.A. and Galione, A. Nicotinic acid-adenine dinucleotide phosphate mobilizes Ca2+ from a thapsigargin-insensitive pool. Biochem. J. 315, 721–725 (1996). The first report that NAADP can mobilize Ca2+ from stores distinct from the ER.
  7. Berridge, M., Lipp, P., and Bootman, M. The versatility and universality of calcium signalling. Nat. Mol. Cell Biol. Rev. 1, 11–21 (2000).
  8. Chini, E.N. and Dousa, T.P. Nicotinate-adenine dinucleotide phosphate-induced Ca2+-release does not behave as a Ca2+-induced Ca2+-release system. Biochem. J. 316, 709–711 (1996).
  9. Churchill, G.C. and Galione, A. NAADP induces Ca2+ oscillations via a two-pool mechanism by priming IP3- and cADPR-sensitive Ca2+ stores. EMBO J. 20, 2666–2671 (2001).[CrossRef][Medline]
  10. Lee, H.C. and Aarhus, R. Functional visualization of the separate but interacting calcium stores sensitive to NAADP and cyclic ADP-ribose. J. Cell Sci. 113, 4413–4420 (2000).[Abstract]
  11. Churchill, G.C., Okada, Y., Thomas, J.M., Armando A. Genazzani, Patel, S., and Galione, A. NAADP mobilizes Ca2+ from reserve granules, a lysosome-related organelle, in sea urchin eggs. Cell 111, 703–708 (2002). First report of acidic compartments as NAADP-sensitive Ca2+ stores.[CrossRef][Medline]
  12. Terasaki, M., Miyake, K., and McNeil, P.L. Large plasma membrane disruptions are rapidly resealed by Ca2+-dependent vesicle-vesicle fusion events. J. Cell Biol. 139, 63–74 (1997).[Abstract/Free Full Text]
  13. Gerasimenko, J.V., Gerasimenko, O.V., and Petersen, O.H. Membrane repair: Ca2+-elicited lysosomal exocytosis. Curr. Biol. 11, R971–R974 (2001).[CrossRef][Medline]
  14. Churchill, G.C., O’Neill, J.S., Masgrau, R., Patel, S., Thomas, J.M., Genazzani, A.A., and Galione, A. Sperm deliver a new second messenger, NAADP. Curr. Biol. 13, 125–128 (2003). First report of changes in NAADP levels in response to a cellular stimulus.[CrossRef][Medline]
  15. Moccia, F., Lim, D., Kyozuka, K., and Santella, L. NAADP triggers the fertilization potential in starfish oocytes. Cell Calcium 36, 515–524 (2004).[CrossRef][Medline]
  16. Langhorst, M.F., Schwarzmann, N., and Guse, A.H. Ca2+ release via ryanodine receptors and Ca2+ entry: Major mechanisms in NAADP-mediated Ca2+ signaling in T-lymphocytes. Cell Signal. 16, 1283–1289 (2004).[CrossRef][Medline]
  17. Patel, S., Churchill, G.C., and Galione, A. Unique kinetics of nicotinic acid-adenine dinucleotide phosphate (NAADP) binding enhance the sensitivity of NAADP receptors for their ligand. Biochem. J. 352, 725–729 (2000).
  18. Billington, R.A. and Genazzani, A.A. Characterization of NAADP+ binding in sea urchin eggs. Biochem. Biophys. Res. Commun. 276, 112–116 (2000).[CrossRef][Medline]
  19. Berridge, G., Dickinson, G., Parrington, J., Galione, A., and Patel, S. Solubilization of receptors for the novel Ca2+-mobilizing messenger, nicotinic acid adenine dinucleotide phosphate. J. Biol. Chem. 277, 43717–43723 (2002).[Abstract/Free Full Text]
  20. Cancela, J.M., Churchill, G.C., and Galione, A. Coordination of agonist-induced Ca2+-signalling patterns by NAADP in pancreatic acinar cells. Nature 398, 74–76 (1999). First report of NAADP action in a mammalian cell, and also its involvement in the transduction of receptor mediated Ca2+ signaling.[CrossRef][Medline]
  21. Nielsen, S.P. and Petersen, O.H. Transport of calcium in the perfused submandibular gland of the cat. J. Physiol. 223, 685–697 (1972). The first paper to describe agonist-elicited Ca2+ release from intracellular non-mitochondrial stores.[Abstract/Free Full Text]
  22. Streb, H., Irvine, R.F., Berridge, M.J., and Schulz, I. Release of Ca2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate. Nature 306, 67–69 (1983). The first paper to describe the Ca2+ releasing action of InsP3.[CrossRef][Medline]
  23. Osipchuk, Y.V., Wakui, M., Yule, D.I., Gallacher, D.V., and Petersen, O.H. Cytoplasmic Ca2+ oscillations evoked by receptor stimulation, G-protein activation, internal application of inositol trisphosphate or Ca2+: Simultaneous microfluorimetry and Ca2+-dependent Cl current recording in single pancreatic acinar cells. EMBO J. 9, 697–704 (1990).[Medline]
  24. Cancela, J.M., Van Coppenolle, F., Galione, A., Tepikin, A.V., and Petersen, O.H. Transformation of local Ca2+ spikes to global Ca2+ transients: The combinatorial roles of multiple Ca2+ releasing messengers. EMBO J. 21, 909–919 (2002). The first paper to describe the mutually potentiating actions of three different intracellular Ca2+-releasing messengers.[CrossRef][Medline]
  25. Thorn, P., Lawrie, A.M., Smith, P.M., Gallacher, D.V., and Petersen, O.H. Local and global cytosolic Ca2+ oscillations in exocrine cells evoked by agonists and inositol trisphosphate. Cell 74, 661–668 (1993).[CrossRef][Medline]
  26. Thorn, P., Gerasimenko, O., and Petersen, O.H. Cyclic ADP-ribose regulation of ryanodine receptors involved in agonist-evoked cytosolic Ca2+ oscillations in pancreatic acinar cells. EMBO J. 13, 2038–2043 (1994).[Medline]
  27. Wakui, M., Potter, B.V., and Petersen, O.H. Pulsatile intracellular calcium release does not depend on fluctuations in inositol trisphosphate concentration. Nature 339, 317–320 (1989). The first direct experiments showing that a constant InsP3 concentration can elicit pulsatile intracellular Ca2+ release.[CrossRef][Medline]
  28. Cancela, J.M., Gerasimenko, O.V., Gerasimenko, J.V., Tepikin, AV., and Petersen, O.H. Two different but converging messenger pathways to intracellular Ca2+ release: The roles of nicotinic acid adenine dinucleotide phosphate, cyclic ADP-ribose and inositol trisphosphate. EMBO J. 19, 2549–2557 (2000).[CrossRef][Medline]
  29. Ashby, M.C., Craske, M., Park, M.K., Gerasimenko, O.V., Burgoyne, R.D., Petersen, O.H., and Tepikin, A.V. Localized Ca2+ uncaging reveals polarized distribution of Ca2+-sensitive Ca2+ release sites: Mechanism of unidirectional Ca2+ waves. J. Cell Biol. 158, 283–292 (2002). The first direct mapping of Ca2+-induced intracellular Ca2+-release sites.[Abstract/Free Full Text]
  30. Burdakov, D. and Galione, A. Two neuropeptides recruit different messenger pathways to evoke Ca2+ signals in the same cell. Curr. Biol. 10, 993–996 (2000).[CrossRef][Medline]
  31. Gerasimenko, O.V., Gerasimenko, J.V., Rizzuto, R.R., Treiman, M., Tepikin, A.V., and Petersen, O.H. The distribution of the endoplasmic reticulum in living pancreatic acinar cells. Cell Calcium 32, 261–268 (2002).[CrossRef][Medline]
  32. Clapham, D.E. Calcium signaling. Cell 80, 259–268 (1995). A good general overview.[CrossRef][Medline]
  33. Petersen, O.H., Gerasimenko, O.V., Gerasimenko, J.V., Mogami, H., and Tepikin, A.V. The calcium store in the nuclear envelope. Cell Calcium 23, 87–90 (1998).[CrossRef][Medline]
  34. Gerasimenko, O.V., Gerasimenko, J.V., Tepikin, A.V., and Petersen, O.H. ATP-dependent accumulation and inositol trisphosphate- or cyclic AD-Pribose-mediated release of Ca2+ from the nuclear envelope. Cell 80, 439–444 (1995). The first experiments directly demonstrating that the nuclear envelope contains a mobilizable Ca2+ store.[CrossRef][Medline]
  35. Gerasimenko, J.V., Maruyama, Y., Yano, K., Dolman, N.J., Tepikin, A.V., Petersen, O.H., and Gerasimenko, O.V. NAADP mobilizes Ca2+ from a thapsigargin-sensitive store in the nuclear envelope by activating ryanodine receptors. J. Cell Biol. 163, 271–282 (2003).[Abstract/Free Full Text]
  36. Yamasaki, M., Masgrau, R., Morgan, A.J., Churchill, G.C., Patel, S., Ashcroft, S. J., and Galione, A. Organelle selection determines agonist-specific Ca2+ signals in pancreatic acinar and beta cells. J. Biol. Chem. 279, 7234–7240 (2004). First report that specific cellular agonists mobilize Ca2+ from distinct Ca2+ stores depending on the particular messenger mediating the effect.[Abstract/Free Full Text]
  37. Gerasimenko, O.V., Gerasimenko, J.V., Belan, P.V., and Petersen, O.H. Inositol trisphosphate and cyclic ADP-ribose-mediated release of Ca2+ from single isolated pancreatic zymogen granules. Cell 84, 473–480 (1996).[CrossRef][Medline]
  38. Maruyama, Y., Inooka, G., Li, Y.X., Miyashita, Y., and Kasai, H. Agonist-induced localized Ca2+ spikes directly triggering exocytotic secretion in exocrine pancreas. EMBO J. 12, 3017–3022 (1993).[Medline]
  39. Park, M.K., Lomax, R.B., Tepikin, A.V., and Petersen, O.H. Local uncaging of caged Ca2+ reveals distribution of Ca2+-activated Cl channels in pancreatic acinar cells. Proc. Natl. Acad. Sci. U. S. A. 98, 10948–10953 (2001).[Abstract/Free Full Text]
  40. Bak, J., White, P., Timar, G., Missiaen, L., Genazzani, A.A., and Galione, A. Nicotinic acid adenine dinucleotide phosphate triggers Ca2+ release from brain microsomes. Curr. Biol. 9, 751–754 (1999). The first demonstration that NAADP is a Ca2+-mobilizing agent in a mammalian system.[CrossRef][Medline]
  41. Chameau, P., Van De Vrede, Y., Fossier, P., and Baux, G. Ryanodine-, IP3- and NAADP-dependent calcium stores control acetylcholine release. Pflüg. Arch. 443, 289–296 (2001).[CrossRef][Medline]
  42. Brailoiu, E., Patel, S., and Dun, N.J. Modulation of spontaneous transmitter release from the frog neuromuscular junction by interacting intracellular Ca2+ stores: Critical role for nicotinic acid adenine dinucleotide phosphate (NAADP). Biochem. J. 373, 313–318 (2003).[CrossRef][Medline]
  43. Brailoiu, E., Miyamoto, M. D., and Dun, N.J. Nicotinic acid adenine dinucleotide phosphate enhances quantal neurosecretion at the frog neuromuscular junction: Possible action on synaptic vesicles in the releasable pool. Mol. Pharmacol. 60, 718–724. (2001).[Abstract/Free Full Text]
  44. Brailoiu, E., Hoard, J.L., Filipeanu, C.M., Brailoiu, G.C., Dun, S.L., Patel, S., and Dun, N.J. NAADP potentiates neurite outgrowth. J. Biol. Chem. in press (2004).
  45. Johnson, J.D. and Misler, S. Nicotinic acid-adenine dinucleotide phosphate-sensitive calcium stores initiate insulin signaling in human beta cells. Proc. Natl. Acad. Sci. U. S. A. 99, 14566–14571 (2002).[Abstract/Free Full Text]
  46. Masgrau, R., Churchill, G.C., Morgan, A.J., Ashcroft, S.J., and Galione, A. NAADP. A new second messenger for glucose-induced Ca2+ responses in clonal pancreatic beta cells. Curr. Biol. 13, 247–251 (2003).[CrossRef][Medline]
  47. Patel, S. NAADP on the up in pancreatic beta cells-a sweet message? Bioessays 25, 430–433 (2003).[CrossRef][Medline]
  48. Mitchell, K.J., Lai, F.A., and Rutter, G.A. Ryanodine receptor type I and nicotinic acid adenine dinucleotide phosphate receptors mediate Ca2+ release from insulin-containing vesicles in living pancreatic beta-cells (MIN6). J. Biol. Chem. 278, 11057–11064 (2003).[Abstract/Free Full Text]
  49. Boittin, F.X., Galione, A., and Evans, A.M. Nicotinic acid adenine dinucleotide phosphate mediates Ca2+ signals and contraction in arterial smooth muscle via a two-pool mechanism. Circ. Res. 91, 1168–1175 (2002).[Abstract/Free Full Text]
  50. Kinnear, N.P., Boittin, F.X., Thomas, J.M., Galione, A., and Evans, A.M. Lysosome-sarcoplasmic reticulum junctions. A trigger zone for calcium signaling by nicotinic acid adenine dinucleotide phosphate and endothelin-1. J. Biol. Chem. 279, 54319–54326 (2004).[Abstract/Free Full Text]
  51. Yusufi, A.N., Cheng, J., Thompson, M.A., Burnett, J.C., and Grande, J.P. Differential mechanisms of Ca2+ release from vascular smooth muscle cell microsomes. Exp. Biol. Med. (Maywood) 227, 36–44 (2002).[Abstract/Free Full Text]
  52. Bak, J., Billington, R.A., Timar, G., Dutton, A.C., and Genazzani, A.A. NAADP receptors are present and functional in the heart. Curr. Biol. 11, 987–990 (2001).[CrossRef][Medline]
  53. Hohenegger, M., Suko, J., Gscheidlinger, R., Drobny, H., and Zidar, A. Nicotinic acid adenine dinucleotide phosphate, NAADP, activates the skeletal muscle ryanodine receptor. Biochem. J. 367, 423–431 (2002).[CrossRef][Medline]
  54. Mojzisova, A., Krizanova, O., Zacikova, L., Kominkova, V., and Ondrias, K. Effect of nicotinic acid adenine dinucleotide phosphate on ryanodine calcium release channel in heart. Pflüg. Arch. 441, 674–677 (2001).[CrossRef][Medline]
  55. Copello, J.A., Qi, Y., Jeyakumar, L.H., Ogunbunmi, E., and Fleischer, S. Lack of effect of cADP-ribose and NAADP on the activity of skeletal muscle and heart ryanodine receptors. Cell Calcium 30, 269–284 (2001).[CrossRef][Medline]
  56. Berg, I., Potter, B.V., Mayr, G.W., and Guse, A.H. Nicotinic acid adenine dinucleotide phosphate (NAADP+) is an essential regulator of T-lymphocyte Ca2+-signaling. J. Cell Biol. 150, 581–588 (2000).[Abstract/Free Full Text]
  57. Navazio, L., Bewell, M.A., Siddiqua, A., Dickinson, G.D., Galione, A., and Sanders, D. Calcium release from the endoplasmic reticulum of higher plants elicited by the NADP metabolite nicotinic acid adenine dinucleotide phosphate. Proc. Natl. Acad. Sci. U. S. A. 97, 8693–8698 (2000).[Abstract/Free Full Text]
  58. Aarhus, R., Graeff, R.M., Dickey, D.M., Walseth, T.F., and Lee, H.C. ADP-ribosyl cyclase and CD38 catalyze the synthesis of a calcium- mobilizing metabolite from NADP. J. Biol. Chem. 270, 30327–30333 (1995).[Abstract/Free Full Text]
  59. Galione, A. and Churchill, G.C. Interactions between calcium release pathways: Multiple messengers and multiple stores. Cell Calcium 32, 343–354 (2002).[CrossRef][Medline]
  60. Yusufi, A.N., Cheng, J., Thompson, M.A., Chini, E.N., and Grande, J.P. Nicotinic acid-adenine dinucleotide phosphate (NAADP) elicits specific microsomal Ca2+ release from mammalian cells. Biochem. J. 353, 531–536 (2001).[CrossRef][Medline]
  61. Santella, L., Kyozuka, K., Genazzani, A.A., De Riso, L., and Carafoli, E. Nicotinic acid adenine dinucleotide phosphate-induced Ca2+ release. Interactions among distinct Ca2+ mobilizing mechanisms in starfish oocytes. J. Biol. Chem. 275, 8301–8306 (2000).[Abstract/Free Full Text]
  62. Aarhus, R., Dickey, D.M., Graeff, R.M., Gee, K.R., Walseth, T.F., and Lee, H.C. Activation and inactivation of Ca2+ release by NAADP+. J. Biol. Chem. 271, 8513–8516 (1996).[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Steen, T. Kirchberger, and A. H. Guse
NAADP Mobilizes Calcium from the Endoplasmic Reticular Ca2+ Store in T-lymphocytes
J. Biol. Chem., June 29, 2007; 282(26): 18864 - 18871.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Macgregor, M. Yamasaki, S. Rakovic, L. Sanders, R. Parkesh, G. C. Churchill, A. Galione, and D. A. Terrar
NAADP Controls Cross-talk between Distinct Ca2+ Stores in the Heart
J. Biol. Chem., May 18, 2007; 282(20): 15302 - 15311.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. Soares, M. Thompson, T. White, A. Isbell, M. Yamasaki, Y. Prakash, F. E. Lund, A. Galione, and E. N. Chini
NAADP as a second messenger: neither CD38 nor base-exchange reaction are necessary for in vivo generation of NAADP in myometrial cells
Am J Physiol Cell Physiol, January 1, 2007; 292(1): C227 - C239.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Umesh, M. A. Thompson, E. N. Chini, K.-P. Yip, and J. S. K. Sham
Integrin Ligands Mobilize Ca2+ from Ryanodine Receptor-gated Stores and Lysosome-related Acidic Organelles in Pulmonary Arterial Smooth Muscle Cells
J. Biol. Chem., November 10, 2006; 281(45): 34312 - 34323.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Gasser, S. Bruhn, and A. H. Guse
Second Messenger Function of Nicotinic Acid Adenine Dinucleotide Phosphate Revealed by an Improved Enzymatic Cycling Assay
J. Biol. Chem., June 23, 2006; 281(25): 16906 - 16913.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Brailoiu, D. Churamani, V. Pandey, G. C. Brailoiu, F. Tuluc, S. Patel, and N. J. Dun
Messenger-specific Role for Nicotinic Acid Adenine Dinucleotide Phosphate in Neuronal Differentiation
J. Biol. Chem., June 9, 2006; 281(23): 15923 - 15928.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. Beck, M. Kolisek, L. A. Bagley, A. Fleig, and R. Penner
Nicotinic acid adenine dinucleotide phosphate and cyclic ADP-ribose regulate TRPM2 channels in T lymphocytes
FASEB J, May 1, 2006; 20(7): 962 - 964.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
J. V. Gerasimenko, M. Sherwood, A. V. Tepikin, O. H. Petersen, and O. V. Gerasimenko
NAADP, cADPR and IP3 all release Ca2+ from the endoplasmic reticulum and an acidic store in the secretory granule area
J. Cell Sci., January 15, 2006; 119(2): 226 - 238.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. C. Lee
Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP)-mediated Calcium Signaling
J. Biol. Chem., October 7, 2005; 280(40): 33693 - 33696.
[Full Text] [PDF]


This Article
Right arrow Summary Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Galione, A.
Right arrow Articles by Petersen, O. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galione, A.
Right arrow Articles by Petersen, O. H.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ASPET Journals Pharmacological Reviews Drug Metabolism and Disposition
Molecular Interventions Molecular Pharmacology J Pharmacology and Exp Therapeutics
Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.